Groups Feed

The Bioidentical Hormones Market Research explores a growing sector focused on customized hormonal therapy solutions designed to mimic naturally produced hormones. Increased awareness of hormone imbalances, aging populations, and patient preference for natural formulations are driving global demand.

Pharmaceutical advancements are improving delivery systems, bioavailability, and long-term safety. Compounding pharmacies and wellness clinics are central players, offering tailored solutions under medical supervision.

Clinical studies continue to examine the long-term benefits and potential risks of bioidentical hormone therapy. The market reflects a strong inclination toward integrative and preventive medicine, particularly among women seeking menopause and thyroid balance treatments. Manufacturers are prioritizing quality assurance, safety labeling, and physician education. Regulatory frameworks differ regionally, creating varied market dynamics and growth potential. Continuous innovation in hormone synthesis and delivery technology supports steady market progress.

FAQQ1. What factors drive the Bioidentical Hormones Market?Growing awareness of hormonal health and preference for personalized, natural therapies.Q2. What are…

Hi Dr. Stabin. I hope you are doing Great.

I am planning to do a dosimetry study on a 99mTc labelled PSMA.

We have siemens dual head camera in our department.I have gone through lecture series of data collection. I have one query regarding scatter correction image processing.

For scatter correction using triple energy window method, after whole body acquisition what software is to be used to get the desired scatter corrected image in siemens dual head gamma camera.

Hello Dibya. I am very excited to join this group and discuss topics related to patient dosimetry in the radiopharmaceutical sciences.